AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

"The global regenerative medicine markets comprises of many key market players competing for markets shares like Novartis AG ...

Several key players are shaping the global pruritus therapeutics market. Companies such as Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical ...

Those include having a Psoriasis Area and Severity Index (PASI) of 10 or more – indicating that lesions cover at least 10% of their body – and a Dermatology ... than Amgen’s PDE4 inhibitor ...

Finding products that work well with your skin can be challenging—especially if you have sensitive skin. Many people turn to ...

Social media influencers often promote “age defying” skin care products, encouraging young followers to prevent wrinkles and ...

A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis,” published in the November 2024 issue of Dermatology by Ferris et al.

Amazon One Medical is expanding its telehealth services with the launch of treatment plans and medication delivery for ...

Scores of young people are turning to the generative artificial intelligence platform to ask for advice on skin concerns. For ...

By layering your clothing properly and using these Dermatone products, your adventure will be much more enjoyable. In this two-pack, you will receive two 0.5oz cans of Dermatone products ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...